Vident Advisory, LLC Ironwood Pharmaceuticals Inc Transaction History

Vident Advisory, LLC

  • $3.97 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $32,900 - $43,081
3,743 Added 23.58%
19,619 $224 Million
Q3 2023

Feb 21, 2024
SELL
$8.25 - $11.35 $30,879 - $42,483
-3,743 Reduced 19.08%
15,876 $153 Million
Q3 2023

Nov 14, 2023
BUY
$8.25 - $11.35 $130,977 - $180,192
15,876 New
15,876 $153 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email